Innovation

17 patent families (11 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace steady. Cited 2,934 times.

Year	Filings
2015	6
2016	7
2017	7
2018	8
2019	6
2020	5
2021	6
2022	1
2023	2
2024	2
2025	4
2026	2

Investor mix

11 investors on record; lead investors include F-Prime Capital, Excel Medical Ventures; 1 has since exited.

Investor type	Count	Share
Venture capital	9	82%
Other / undisclosed	2	18%